[1] Akers KS, Chaney C, Barsoumian A, et al. Amino-glycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex [J]. J Clin Microbiol, 2010,48(4):1132-1138.[2] Jung S, Yu JK, Shin SH, et al. False susceptibility to amikacin by VITEK 2 in Acinetobacter baumannii harboring armA [J]. Ann Clin Lab Sci, 2010,40(2):167-171.[3] Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S]. M100-S22, CLSI, 2012.[4] Noppe-Leclercq I, Wallet F, Haentjens S, et al. PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii [J]. Res Microbiol, 1999,150(5):317-322.[5] Gu B, Tong M, Zhao W, et al. Prevalence and characterization of class Ⅰ integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China [J]. J Clin Microbiol, 2007,45(1):241-243.[6] 邓进进, 邵海枫, 王卫萍, 等. 鲍曼不动杆菌对氨基糖苷类抗菌药物双圈耐药现象的初步探讨 [J]. 临床检验杂志, 2008,26(2):90-92.[7] 汪鹏程, 蔡 俊, 闫 敏, 等. 鲍曼不动杆菌对氨基糖苷类药物耐药及其携带基因的探讨 [J]. 国际检验医学杂志, 2012,33(10):1155-1156.[8] 张晓文, 邵海枫, 王卫萍, 等. 导致氨基糖苷类药物双圈耐药型鲍曼不动杆菌的相关携带基因研究 [J]. 临床检验杂志, 2011,29(1):19-21.[9] 张晓文, 邵海枫, 王卫萍, 等. 氨基糖苷类药物双圈耐药型鲍曼不动杆菌16S rRNA甲基化酶基因研究 [J]. 中国抗生素杂志, 2011,36(11):855-858. |